GENELABS TECHNOLOGIES INC /CA 4
4 · GENELABS TECHNOLOGIES INC /CA · Filed Jan 31, 2005
Insider Transaction Report
Form 4
SMITH JAMES ANGUS DUNCAN
President and CEO
Transactions
- Disposition to Issuer
Option Grant
2005-01-27$0.88/sh+80,000$70,400→ 80,000 totalExercise: $0.88Exp: 2015-01-27→ common stock (80,000 underlying)
Footnotes (1)
- [F1]these options become 50% exercisable on June 30, 2005 and the remainder pro rata monthly over the next six months.